MYKK7 VIGOUR VITALITY NEWS

13/02/2026

A first-of-its-kind device for pancreatic cancer treatment has been approved by the U.S. Food and Drug Administration. https://www.wfla.com/bloom-tampa-bay/bloom-health-and-wellness/first-of-its-kind-device-to-treat-pancreatic-cancer-receives-fda-approval/

19/01/2026

Diseases such as Nipah virus are best addressed through the One Health approach, which recognizes the interconnectedness of human, animal, and environmental health.

Strengthening integrated surveillance, early detection, and preventive measures is essential to reducing risk and preventing outbreaks.



Narendra Modi PMO India J.P.Nadda Prataprao Jadhav Anupriya Patel अनुप्रिया पटेल Press Information Bureau - PIB, Government of India Ministry of Information & Broadcasting, Government of India MyGovIndia DDNewsLive All India Radio News

13/12/2025

For the first time in decades, the US Food and Drug Administration has signed off on new antibiotics to fight gonorrhea. The approvals come at a critical moment: The sexually transmitted infection is growing harder to treat, and cases continue to climb nationwide. https://cnn.it/3MGex4S

09/12/2024

A Shanghai patient with a spinal cord injury that paralysed his arm has been able to open a bottle cap and drink water.

(Link in comments)

29/09/2024

Give your heart the precious care it deserves,
World Heart Day 2024 🫀

01/06/2024

The tech brand Apple is extremely popular across the world and its devices are often known to save lives of people, because of its advanced features.

In a latest related development, the company’s augmented reality (AR) device, Apple Vision Pro has been used in one of the surgical centres of Pristyn Care in the national capital, for a live bariatric surgery.

It is for the first time that the device has been used for something like this and it lasted for 40 minutes, on a 45-year-old patient weighing 155 KG.

Apple Vision Pro Used In Live Bariatric Surgery As mentioned earlier, AR device Apple Vision Pro has been used in a live bariatric surgery for the first time ever.

31/05/2024

Clinical trials for the world's first "tooth regrowth medicine" will begin in September at Kyoto University Hospital, researchers announced on May 2.

The medicine will initially be tested on healthy individuals, with patients suffering from congenital tooth deficiency to follow. The aim is to confirm the medicine's safety and effectiveness, with hopes to market it by 2030.

The treatment deactivates USAG-1 protein, enabling tooth growth. This breakthrough could benefit those with congenital tooth absence and those who have lost teeth due to cavities or injuries.

31/05/2024

Researchers are developing "smart bandages" which may have the ability to analyze and react to how a wound is healing - and help the process along.

15/02/2024

26/12/2023

A woman who was born with a rare condition known as double uterus gave birth to two twin girls whom she carried in each of her uteruses during her pregnancy.

Kelsey Hatcher of Dora, Alabama, delivered one girl on Tuesday, and another on Wednesday following 20 hours of labor, according to the University of Alabama at Birmingham.

"Our miracle babies were born! They decided they were rare enough statistically that they should just go ahead and have their own birthdays too," Hatcher wrote on Instagram.

Read more about this "one in a million" pregnancy: https://abcn.ws/41zrHE8?utm_source=facebook&utm_medium=social&utm_campaign=dhfacebook&utm_content=app.dashhudson.com%2Fabcnews%2Flibrary%2Fmedia%2F362575875

03/12/2023

Bahrain has achieved a historic milestone by becoming the second country globally and the first in the Middle East to greenlight the utilisation of CASGEVY (exagamglogene autotemcel) for treating patients with sickle cell disease and transfusion-dependent beta-thalassemia. This groundbreaking treatment, developed by Vertex Pharmaceuticals and CRISPR Therapeutics, underwent successful clinical trials in various countries, including the UK, US, France, Italy, and Germany.
Read more https://www.newsofbahrain.com/bahrain/95061.html
🇧🇭 🇬🇧 🇺🇸 🇫🇷 🇮🇹 👨🏽‍🔬👩🏻‍🔬

11/11/2023